A new collaboration between Diagnexia and Algoscope marks an important step forward for digital pathology in the UK. The partnership, which began following initial meetings at DP&AI London and earlier interactions at ECP 2024 in Florence, is rooted in a shared focus on quality, speed, and innovation.

Diagnexia, with an established presence across the USA, Canada, and the UK, has developed a scalable model that combines digital infrastructure with subspecialty expertise to deliver high-quality pathology services. This alignment in approach made the organisation a natural choice as Algoscope’s first UK partner.

As part of this collaboration, Diagnexia has become the first UK organisation to adopt VoxelPath technology, acquiring two devices for its Oxford laboratory. The implementation was carried out in close coordination with biomedical scientists and IT teams, ensuring a fully integrated and efficient workflow from the outset.

Together, the two organisations are introducing the AlgoPath ecosystem to the UK, with the aim of enhancing workflow quality, traceability, and diagnostic efficiency. This partnership represents a significant milestone for both teams and signals continued progress in the adoption of advanced digital pathology solutions.